A clear approach: Hemostatic gel as a novel adjunct for pediatric upper gastrointestinal bleeding.

JPGN reports Pub Date : 2025-02-03 eCollection Date: 2025-05-01 DOI:10.1002/jpr3.70000
Natalia Plott, Audra Rougraff, Paroma Bose, Kyla M Tolliver, Shamaila Waseem, Brett J Hoskins
{"title":"A clear approach: Hemostatic gel as a novel adjunct for pediatric upper gastrointestinal bleeding.","authors":"Natalia Plott, Audra Rougraff, Paroma Bose, Kyla M Tolliver, Shamaila Waseem, Brett J Hoskins","doi":"10.1002/jpr3.70000","DOIUrl":null,"url":null,"abstract":"<p><p>Pediatric upper gastrointestinal bleeding (UGIB) is a significant clinical concern, with a mortality rate of approximately 2%. Endoscopic management of UGIB in children includes various techniques such as injections, mechanical devices, thermal therapies, and topical agents. PuraStat®, a clear hemostatic gel, has been used in adults to create a physical barrier for hemostasis without obscuring the endoscopic view. However, its use in pediatric UGIB has not been well-documented. A review of four pediatric cases where PuraStat® was used to treat UGIB showed that it was applied as an adjunct to other hemostatic methods like clip placement or epinephrine injections, and in one case, as monotherapy for a large duodenal ulcer/site of recently contained perforation. The gel was easy to use, appeared to be beneficial, and was well-tolerated in this small cohort, although conclusions regarding its safety and efficacy are limited by the sample size.</p>","PeriodicalId":501015,"journal":{"name":"JPGN reports","volume":"6 2","pages":"157-161"},"PeriodicalIF":0.0000,"publicationDate":"2025-02-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12078060/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JPGN reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/jpr3.70000","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/5/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Pediatric upper gastrointestinal bleeding (UGIB) is a significant clinical concern, with a mortality rate of approximately 2%. Endoscopic management of UGIB in children includes various techniques such as injections, mechanical devices, thermal therapies, and topical agents. PuraStat®, a clear hemostatic gel, has been used in adults to create a physical barrier for hemostasis without obscuring the endoscopic view. However, its use in pediatric UGIB has not been well-documented. A review of four pediatric cases where PuraStat® was used to treat UGIB showed that it was applied as an adjunct to other hemostatic methods like clip placement or epinephrine injections, and in one case, as monotherapy for a large duodenal ulcer/site of recently contained perforation. The gel was easy to use, appeared to be beneficial, and was well-tolerated in this small cohort, although conclusions regarding its safety and efficacy are limited by the sample size.

一个明确的方法:止血凝胶作为儿科上消化道出血的一种新的辅助手段。
儿科上消化道出血(UGIB)是一个重要的临床问题,死亡率约为2%。儿童UGIB的内镜治疗包括各种技术,如注射、机械装置、热疗法和局部药物。PuraStat®是一种透明止血凝胶,已用于成人,在不遮挡内镜视野的情况下为止血创造物理屏障。然而,它在儿科UGIB中的应用尚未得到充分的证明。对4例使用PuraStat®治疗UGIB的儿童病例的回顾显示,它被用作其他止血方法(如夹置或肾上腺素注射)的辅助疗法,并且在1例中,作为大十二指肠溃疡/最近包含穿孔的部位的单一疗法。凝胶易于使用,似乎是有益的,并且在这个小队列中耐受性良好,尽管关于其安全性和有效性的结论受到样本量的限制。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信